» Articles » PMID: 10563606

Painful Sensory Neuropathy: Prospective Evaluation Using Skin Biopsy

Overview
Journal Neurology
Specialty Neurology
Date 1999 Nov 24
PMID 10563606
Citations 60
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: In patients presenting with painful, burning feet with minimal signs of neuropathy, the following questions were addressed: 1) How many of these patients have a peripheral neuropathy? 2) What is the role of skin biopsy in establishing a diagnosis of neuropathy? 3) What conditions are associated with the neuropathy? and 4) What laboratory studies are useful in this patient population?

Methods: A total of 117 consecutive patients referred for evaluation were prospectively studied. All underwent nerve conduction studies (NCS) and a battery of blood tests, including antinerve antibodies. If NCS were normal, a punch biopsy of the skin of the distal leg was performed to ascertain the intraepidermal nerve fiber (IENF) density. In a subset of 32 patients, the sensitivity of skin biopsy was compared to quantitative sudomotor axon test (QSART) and quantitative sensory tests (QST).

Results: Three groups emerged. Group 1, with abnormal NCS (n = 60, 34 F/26 M, mean age 60 +/- 14 years), represented 51% of the cohort. The majority had neuropathies of undetermined cause, but 18 (30%) had associated conditions. Group 2, with normal NCS and reduced IENF density (n = 44, 29 F/15 M, mean age 57 +/- 14 years), represented 38% of the cohort. Three in this group had associated conditions. Group 3, with normal NCS and IENF density (n = 13, 6 F/7 M, mean age 53 +/- 13 years), represented 11% of the cohort; most had no diagnoses but two had MS. In a comparative subset analysis, skin biopsy was more sensitive than QSART or QST in diagnosing a neuropathy.

Conclusions: Patients presenting with painful feet are heterogeneous, consisting of both large and small fiber sensory neuropathies. In rare cases, a central cause for pain can be found. Over one-third of patients required a skin biopsy to diagnose a small fiber sensory neuropathy. A limited battery of blood tests facilitated diagnosis, but serum antinerve antibodies were not helpful.

Citing Articles

Studying serum neurofilament light chain levels as a potential new biomarker for small fiber neuropathy.

Baka P, Steenken L, Escolano-Lozano F, Steffen F, Papagianni A, Sommer C Eur J Neurol. 2024; 31(4):e16192.

PMID: 38189534 PMC: 11235889. DOI: 10.1111/ene.16192.


Modifying quantitative sensory testing to investigate behavioral reactivity in a pediatric global developmental delay sample: Relation to peripheral innervation and chronic pain outcomes.

Symons F, Burkitt C, Wilcox G, McAdams B, Wendelschafer-Crabb G, Kennedy W Dev Psychobiol. 2022; 64(8):e22329.

PMID: 36426784 PMC: 9708098. DOI: 10.1002/dev.22329.


Investigation of nerve fibers in the skin by biopsy: technical aspects, indications, and contribution to diagnosis of small-fiber neuropathy.

Raicher I, Ravagnani L, Correa S, Dobo C, Mangueira C, Macarenco R Einstein (Sao Paulo). 2022; 20:eMD8044.

PMID: 35830153 PMC: 9262281. DOI: 10.31744/einstein_journal/2022MD8044.


The Armadillo as a Model for Leprosy Nerve Function Impairment: Preventative and Therapeutic Interventions.

Pena M, Lahiri R, Ebenezer G, Wheat S, Figarola J, Truman R Front Med (Lausanne). 2022; 9:879097.

PMID: 35814754 PMC: 9259846. DOI: 10.3389/fmed.2022.879097.


The Value of In Vivo Reflectance Confocal Microscopy as an Assessment Tool in Chemotherapy-Induced Peripheral Neuropathy: A Pilot Study.

Ramnarine S, Dougherty P, Rolke R, Williams L, Alessi-Fox C, Coleman A Oncologist. 2022; 27(8):e671-e680.

PMID: 35706109 PMC: 9355818. DOI: 10.1093/oncolo/oyac106.